Related Experiment Videos
Membrane-type metalloproteinases in tumor invasion
1INSERM U.314, Unité de Biologie Cellulaire, Laboratoire Pol Bouin, CHU Maison Blanche, Reims, France.
The International Journal of Biochemistry & Cell Biology
|December 5, 1998
Summary
Matrix metalloproteinases (MMPs), particularly membrane-type MMPs (MT-MMPs), are crucial in extracellular matrix remodeling and tumor invasion. Their overexpression in tumors highlights potential therapeutic targets like Marimastat.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are zinc-dependent enzymes degrading extracellular matrix (ECM).
- Membrane-type MMPs (MT-MMPs), especially MT1-MMP, activate progelatinase A (MMP-2) and remodel ECM.
- MT1-MMP is implicated in tumor invasion through ECM degradation.
Purpose of the Study:
- To elucidate the role of MT-MMPs in ECM remodeling and tumor invasion.
- To investigate the activation mechanisms of progelatinase A by MT1-MMP.
- To highlight the therapeutic potential of MMP inhibitors in cancer treatment.
Main Methods:
- Analysis of MMP and MT-MMP molecular structures and functions.
- Investigation of MT1-MMP's role in ECM component degradation and progelatinase A activation.
- In vivo and in vitro studies on MT1-MMP expression in tumor tissues and cells.
Main Results:
- MT1-MMP activates progelatinase A and directly cleaves ECM macromolecules like collagen and fibronectin.
- MT1-MMP is overexpressed in stromal cells surrounding tumors and in invasive tumor cells.
- Cooperation between tumor and stromal cells in MT-MMP production contributes to tumor invasion.
Conclusions:
- MT-MMPs, particularly MT1-MMP, are key players in ECM remodeling and tumor metastasis.
- Targeting MMPs, such as with Marimastat, offers a promising therapeutic strategy for cancer treatment.